Sebastian Bruera1, Gary Chisholm2, Renata Dos Santos3, Camila Crovador3, Eduardo Bruera1, David Hui4. 1. Department of Palliative Care and Rehabilitation Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA. 2. Department of Biostatistics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA. 3. Department of Palliative Care, Barretos Cancer Hospital, Barretos, Brazil. 4. Department of Palliative Care and Rehabilitation Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA. Electronic address: dhui@mdanderson.org.
Abstract
CONTEXT: Few studies have examined variation in vital signs in the last days of life. OBJECTIVES: We determined the variation of vital signs in the final two weeks of life in patients with advanced cancer and examined their association with impending death in three days. METHODS: In this prospective, longitudinal, observational study, we enrolled consecutive patients admitted to two acute palliative care units and documented their vital signs (heart rate, blood pressure, respiratory rate, oxygen saturation, and temperature) twice a day serially from admission to death or discharge. RESULTS: Of 357 patients, 203 (57%) died in hospital. Systolic blood pressure (P < 0.001), diastolic blood pressure (P < 0.001), and oxygen saturation (P < 0.001) decreased significantly in the final three days of life, and temperature increased slightly (P < 0.04). Heart rate (P = 0.22) and respiratory rate (P = 0.24) remained similar in the last three days. Impending death in three days was significantly associated with increased heart rate (odds ratio [OR] = 2; P = 0.01), decreased systolic blood pressure (OR = 2.5; P = 0.004), decreased diastolic blood pressure (OR = 2.3; P = 0.002), and decreased oxygen saturation (OR = 3.7; P = 0.003) from baseline readings on admission. These changes had high specificity (≥ 80%), low sensitivity (≤ 35%), and modest positive likelihood ratios (≤ 5) for impending death within three days. A large proportion of patients had normal vital signs in the last days of life. CONCLUSION: Blood pressure and oxygen saturation decreased in the last days of life. Clinicians and families cannot rely on vital sign changes alone to rule in or rule out impending death. Our findings do not support routine vital signs monitoring of patients who are imminently dying.
CONTEXT: Few studies have examined variation in vital signs in the last days of life. OBJECTIVES: We determined the variation of vital signs in the final two weeks of life in patients with advanced cancer and examined their association with impending death in three days. METHODS: In this prospective, longitudinal, observational study, we enrolled consecutive patients admitted to two acute palliative care units and documented their vital signs (heart rate, blood pressure, respiratory rate, oxygen saturation, and temperature) twice a day serially from admission to death or discharge. RESULTS: Of 357 patients, 203 (57%) died in hospital. Systolic blood pressure (P < 0.001), diastolic blood pressure (P < 0.001), and oxygen saturation (P < 0.001) decreased significantly in the final three days of life, and temperature increased slightly (P < 0.04). Heart rate (P = 0.22) and respiratory rate (P = 0.24) remained similar in the last three days. Impending death in three days was significantly associated with increased heart rate (odds ratio [OR] = 2; P = 0.01), decreased systolic blood pressure (OR = 2.5; P = 0.004), decreased diastolic blood pressure (OR = 2.3; P = 0.002), and decreased oxygen saturation (OR = 3.7; P = 0.003) from baseline readings on admission. These changes had high specificity (≥ 80%), low sensitivity (≤ 35%), and modest positive likelihood ratios (≤ 5) for impending death within three days. A large proportion of patients had normal vital signs in the last days of life. CONCLUSION: Blood pressure and oxygen saturation decreased in the last days of life. Clinicians and families cannot rely on vital sign changes alone to rule in or rule out impending death. Our findings do not support routine vital signs monitoring of patients who are imminently dying.
Authors: A Caraceni; O Nanni; M Maltoni; L Piva; M Indelli; E Arnoldi; M Monti; L Montanari; D Amadori; F De Conno Journal: Cancer Date: 2000-09-01 Impact factor: 6.860
Authors: Kavitha J Ramchandran; Joseph W Shega; Jamie Von Roenn; Mark Schumacher; Eytan Szmuilowicz; Alfred Rademaker; Bing Bing Weitner; Pooja D Loftus; Isabella M Chu; Sigmund Weitzman Journal: Cancer Date: 2013-03-15 Impact factor: 6.860
Authors: M Pirovano; M Maltoni; O Nanni; M Marinari; M Indelli; G Zaninetta; V Petrella; S Barni; E Zecca; E Scarpi; R Labianca; D Amadori; G Luporini Journal: J Pain Symptom Manage Date: 1999-04 Impact factor: 3.612
Authors: J C Weeks; E F Cook; S J O'Day; L M Peterson; N Wenger; D Reding; F E Harrell; P Kussin; N V Dawson; A F Connors; J Lynn; R S Phillips Journal: JAMA Date: 1998-06-03 Impact factor: 56.272
Authors: Victoria Louise Reid; Rachael McDonald; Amara Callistus Nwosu; Stephen R Mason; Chris Probert; John E Ellershaw; Séamus Coyle Journal: PLoS One Date: 2017-04-06 Impact factor: 3.240
Authors: Idar Johan Brekke; Lars Håland Puntervoll; Peter Bank Pedersen; John Kellett; Mikkel Brabrand Journal: PLoS One Date: 2019-01-15 Impact factor: 3.240
Authors: Lucien Wasingya-Kasereka; Pauline Nabatanzi; Immaculate Nakitende; Joan Nabiryo; Teopista Namujwiga; John Kellett Journal: Resusc Plus Date: 2020-12-07